<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2019-12-28</publicationDate>
    
        <volume>12</volume>
        <issue>04</issue>

 
    <startPage>2087</startPage>
    <endPage>2089</endPage>

	 
      <doi>10.13005/bpj/1843</doi>
        <publisherRecordId>29866</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">An Unusual Case of Human Intravenous Immunoglobulin Induced Erythema Multiforme in a Child.</title>

    <authors>
	 


      <author>
       <name>Kamalakshi G. Bhat</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name> Amrita Parida</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Ashwin Kamath</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Rashmi R. Rao</name>

		
	<affiliationId>2</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Paediatrics, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka 575001. India.</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Pharmacology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka 575001. India.</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng"><p style="text-align: left;">Human intravenous immunoglobulin (IVIG) is used for diverse conditions is a relatively safe drug with fewer adverse effects. Here, we report a rare case of IVIG-induced erythema multiforme in a four-year-old female child. The child tolerated the initial doses of IVIG well; however, following the fifth dose, she developed multiple erythematous rash over the trunk, upper and lower limbs associated with itching. She was diagnosed to have IVIG-induced erythema multiforme and treated symptomatically and recovered completely within a week. There is limited literature available related to IVIG-induced erythema multiforme; hence we decided to report this case.</p></abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol12no4/an-unusual-case-of-human-intravenous-immunoglobulin-induced-erythema-multiforme-in-a-child/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Adverse Drug Reaction</keyword>
      

      
        <keyword> Erythema Multiforme</keyword>
      

      
        <keyword> Human IVIG</keyword>
      
</keywords>
  </record>
</records>